Caris Life Sciences Inc (CAI) PT Raised to $30 at Canaccord Genuity
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts CAI Hot Sheet
Price: $33.67 +3.73%
Rating Summary:
12 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 18
Rating Summary:
12 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 18
Join SI Premium – FREE
Canaccord Genuity analyst Kyle Mikson raised the price target on Caris Life Sciences Inc (NASDAQ: CAI) to $30.00 (from $28.00) while maintaining a Buy rating.
You May Also Be Interested In
- Caris Life Sciences Inc (CAI) PT Raised to $38 at BTIG
- Brown & Brown (BRO) PT Lowered to $85 at Truist Securities
- Ballard Power Systems (BLDP) PT Lowered to $1.68 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
